Vineet Agarwal - Oct 17, 2024 Form 4 Insider Report for Korro Bio, Inc. (KRRO)

Role
Chief Financial Officer
Signature
/s/ Vineet Agarwal
Stock symbol
KRRO
Transactions as of
Oct 17, 2024
Transactions value $
-$677,059
Form type
4
Date filed
10/18/2024, 07:43 PM
Previous filing
Nov 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRRO Common Stock Options Exercise $108K +9.26K $11.68 9.26K Oct 17, 2024 Direct F1
transaction KRRO Common Stock Options Exercise $14.3K +953 +10.29% $14.98 10.2K Oct 17, 2024 Direct F1
transaction KRRO Common Stock Sale -$145K -2.02K -19.8% $71.51 8.19K Oct 17, 2024 Direct F1, F2
transaction KRRO Common Stock Sale -$12.1K -164 -2% $73.71 8.03K Oct 17, 2024 Direct F1, F3
transaction KRRO Common Stock Sale -$8.57K -115 -1.43% $74.56 7.91K Oct 17, 2024 Direct F1, F4
transaction KRRO Common Stock Sale -$4.26K -56 -0.71% $76.00 7.86K Oct 17, 2024 Direct F1
transaction KRRO Common Stock Sale -$1.77K -23 -0.29% $77.00 7.84K Oct 17, 2024 Direct F1
transaction KRRO Common Stock Sale -$20.2K -260 -3.32% $77.55 7.58K Oct 17, 2024 Direct F1, F5
transaction KRRO Common Stock Sale -$35.9K -457 -6.03% $78.59 7.12K Oct 17, 2024 Direct F1, F6
transaction KRRO Common Stock Sale -$145K -1.82K -25.5% $79.79 5.3K Oct 17, 2024 Direct F1, F7
transaction KRRO Common Stock Sale -$399K -4.96K -93.55% $80.50 342 Oct 17, 2024 Direct F1, F8
transaction KRRO Common Stock Sale -$25.8K -317 -92.69% $81.48 25 Oct 17, 2024 Direct F1, F9
transaction KRRO Common Stock Sale -$2.07K -25 -100% $82.89 0 Oct 17, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRRO Stock Option (Right to Buy) Options Exercise $0 -9.26K -22.66% $0.00 31.6K Oct 17, 2024 Common Stock 9.26K $11.68 Direct F1, F10
transaction KRRO Stock Option (Right to Buy) Options Exercise $0 -953 -2.05% $0.00 45.6K Oct 17, 2024 Common Stock 953 $14.98 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 19, 2024.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.965 to $71.94, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.30 to $73.975, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.51 to $74.90, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.01 to $78.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
F6 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.07 to $78.935, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
F7 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.12 to $80.115, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
F8 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.15 to $81.14, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
F9 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.20 to $82.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
F10 The shares subject to the option vest as to 25% of the shares on May 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F11 The shares subject to the option vest in 48 equal monthly installments commencing from November 3, 2023, subject to the Reporting Person's continued service on each such vesting date.